1 / 14

Evidence, guidelines and practice: the way forward in a digital age

- Evidence, warts and all -. Evidence, guidelines and practice: the way forward in a digital age . SYDNEY 11 April, 2013 Bill Runciman Professor – Patient Safety & Healthcare Human Factors – University of South Australia - Centre for Sleep Research

vivek
Télécharger la présentation

Evidence, guidelines and practice: the way forward in a digital age

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. - Evidence, warts and all - Evidence, guidelines and practice: the way forward in a digital age SYDNEY 11 April, 2013 Bill Runciman Professor – Patient Safety & Healthcare Human Factors – University of South Australia- Centre for Sleep Research Research Fellow, Australian Institute of Health Innovation, University of NSW Clinical Professor – Joanna Briggs Institute, Faculty Health Sciences – The University of Adelaide President, Australian Patient Safety Foundation Adam Dunn Senior Research Fellow, Australian Institute of Health Innovation

  2. - Evidence - • Evidence is and includes everything that is used to reveal and determine the truth • Giving or procuring evidence is the process of using those things that are: • Presumed to be true or are • Proven by prior evidence (truth)

  3. - Evidence - Eccles et al - Evidence from: Ia - meta-analysis of RCT’s Ib - at least one RCT II - at least one controlled study without randomisation III - comparative studies care-control studies correlation studies IV - consensus (expert reports/opinions)

  4. - Consensus - “Experts”: self-selected, sometimes contaminated by vested interests • commercial • professional • personal • financial Guidelines that don’t guide

  5. - Evidence issues and effects - Over claiming (efficacy, safety) Proclamations of “new standard of care” Over-diagnosis Over-testing Over-monitoring Over-treating Bias-dishonesty

  6. - Evidence –Bias - dishonesty Design biases Publication biases Reporting biases Synthesis biases Marketing biases Media biases Denial/concealment biases

  7. - Design biases - Little comparative effectiveness research Deliberate avoidance of unfavourable comparisons Unethical placebo studies Low doses of comparators for drugs

  8. - Publication biases - Non-publication of negative results Refusal to allow scrutiny of data Duplicate publications Re-using subject data

  9. - Reporting biases - Industry influence Shadow writers Results not those foreshadowed in trial registers Unwarranted conclusions which do not match the results Partial or biased reporting leading to distortions (safety, efficacy)

  10. - Citation biases - Citation distortions can create unfounded authority Unfavourable studies can be ignored Supportive evidence can be over-cited

  11. - Synthesis bias - Search and citation criteria Interpretation of articles found Selection of articles found Creation of presumptions “Low level” evidence ignored or discounted

  12. - Other biases - • Marketing biases • off label prescribing • direct marketing • Media biases • Denial/concealment biases • Threats to “whistle-blowers”

  13. - What should we do? - Review the whole area Develop further checklists Regulation ??? Transparency Penalties ??? Discount studies Publicity ??? Conflicts of interest ???

More Related